CELG

Celgene Corporation News Headlines

$119.57
*  
1.10
0.93%
Get CELG Alerts
*Delayed - data as of Mar. 4, 2015  -  Find a broker to begin trading CELG now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Amgen Still In Play With Endeavor To Expand Kyprolis
3/4/2015 10:10:00 AM - Seeking Alpha


Celgene To Present At Cowen Health Care Conference; Webcast At 10:00 AM ET
3/4/2015 9:01:00 AM - RTT News


Celgene's Abraxane Combination Therapy Cleared in the EU - Analyst Blog
3/3/2015 6:33:00 PM - Zacks.com


Pioneer Fundamental Growth Fund: Why Is It Revving Up?
3/3/2015 5:22:00 PM - Investor's Business Daily


Amgen: The Best Biotech Stock You Don't Own
3/3/2015 5:04:00 PM - Seeking Alpha


Ligand Pharmaceuticals Weakens The Bear Case
3/3/2015 11:17:00 AM - Seeking Alpha


Investors Are Best To Avoid The IShares Nasdaq Biotechnology ETF
3/2/2015 10:24:00 AM - Seeking Alpha


Celgene : EC Approves ABRAXANE For First-Line Treatment Of Patients With NSCLC
3/2/2015 9:50:00 AM - RTT News


Amgen's Long Case Strengthens After Kyprolis Data
3/2/2015 8:41:00 AM - Seeking Alpha


3 Big Cap Biotechs That Could Trounce Gilead Sciences This Year
3/1/2015 7:12:02 AM - Motley Fool


iShares S&P 500 Growth ETF Experiences Big Outflow
2/27/2015 10:54:25 AM - BNK Invest


Biotech Head-to-Head: Gilead vs. Celgene
2/26/2015 12:03:02 PM - Motley Fool


Biotech Stock Roundup: Pharmacyclics Up on Buyout Rumors, Celgene Drug Label Expanded - Analyst Blog
2/26/2015 11:07:00 AM - Zacks.com


ModernGraham Quarterly Valuation Of Celgene Corporation
2/26/2015 10:48:00 AM - Seeking Alpha


Can Celgene Corporation Climb Another 26%?
2/26/2015 9:21:02 AM - Motley Fool


Heavy Institutional Buying Is Occurring In MEI Pharma, Topline Data Due In Mid-March
2/26/2015 8:30:00 AM - Seeking Alpha


SanDisk Has Disappointed Twice - Cramer's Lightning Round (2/25/15)
2/26/2015 5:51:00 AM - Seeking Alpha


The Single Best Stock to Own Today
2/25/2015 7:04:02 PM - Motley Fool


Why Pharmacyclics, Inc. Soared Higher Today
2/25/2015 3:07:27 PM - Motley Fool


S&P 500 Analyst Moves: CELG
2/24/2015 2:12:45 PM - BNK Invest


ABRAXANE Now Reimbursed In Italy As First-Line Treatment For Pancreatic Cancer
2/24/2015 8:15:00 AM - RTT News


Market Is Not In A Bubble - Cramer's Mad Money (2/23/15)
2/24/2015 7:40:00 AM - Seeking Alpha


Celgene To Present At RBC Capital Markets Conference; Webcast At 8:00 AM ET
2/24/2015 7:00:00 AM - RTT News


Enbridge Energy Partners Is Cheap - Cramer's Lightning Round (2/23/15)
2/24/2015 5:53:00 AM - Seeking Alpha


Celgene Gains on Label Expansion of Revlimid in the EU - Analyst Blog
2/23/2015 6:20:00 PM - Zacks.com